Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times
By A Mystery Man Writer
Description
F.D.A. Names and Shames Drug Makers to Encourage Generic Competition - The New York Times
Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban
Opinion Our Generic Drug Supply Is Sick - The New York Times
Is GSK A Good Choice For Dividend Investors?
Glaxo, Pfizer joint venture creates world's largest supplier of over-the-counter drugs - Los Angeles Times
Brands Like GlaxoSmithKline Begin to Sell Generic Drugs - The New York Times, generic
Britain Accuses GlaxoSmithKline of Conspiring With Rivals Over Generics - The New York Times
Defiant, Generic Drug Maker Continues to Raise Prices - The New York Times
Drugmakers Throw 'Kitchen Sink' to Halt Medicare Price Negotiations - The New York Times
China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case - The New York Times
Novartis Leaning Toward Spinoff of $25 Billion Generics Arm - BNN Bloomberg
A 29-year-old former Wall Streeter bought an Alzheimer's drug that failed clinical trials — and now his company is worth $3 billion
Brand Institute: The World's #1 Naming Company
from
per adult (price varies by group size)